oral glp 1 agonist GLP-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and obesity care. Amid the enthusiasm, however, a quieter and clinically important issue is Oral GLP-1: A Needle-Free Solution

Description

Only dulaglutide treatment did not decrease TDI, however this was a small study (n=18) (52)

Geiger et al., 2008

Among American adults who have taken these medications, 62% said they used them both to treat a chronic condition such as diabetes or heart disease and to lose weight, including 39% who said they used the medications only to treat a chronic condition

Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects

By addressing the specific pain points these consumers have, like decreased appetite resulting in nutrient deficits or gastrointestinal side effects, you can present your product as the nutritional solution for those who take GLP-1 agonist medications